Marex Group’s Merck MRK Stock Holding History

Marex Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.31M	Buy	10,904 +5,896	+118%	+$681K	0.01%	386
2025 Q4	$527K	Sell	5,008 -18,283	-78%	-$1.72M	﹤0.01%	552
2025 Q3	$1.95M	Sell	23,291 -13,901	-37%	-$1.14M	0.01%	265
2025 Q2	$2.94M	Buy	37,192 +3,135	+9%	+$249K	0.03%	198
2025 Q1	$3.06M	Sell	34,057 -44,359	-57%	-$4.14M	0.06%	140
2024 Q4	$7.8M	Buy	78,416 +65,711	+517%	+$6.77M	0.13%	78
2024 Q3	$1.44M	Sell	12,705 -1,337	-10%	-$159K	0.03%	184
2024 Q2	$1.74M	Sell	14,042 -42,025	-75%	-$5.41M	0.05%	171
2024 Q1	$7.4M	Sell	56,067 -69,425	-55%	-$8.56M	0.24%	64
2023 Q4	$13.7M	Buy	125,492 +122,609	+4,253%	+$12.7M	0.54%	45
2023 Q3	$297K	Buy	+2,883	New	+$311K	0.04%	158
2023 Q2	–	Sell	-7,135	Closed	-$759K	–	282
2023 Q1	$759K	Sell	7,135 -6,837	-49%	-$738K	0.1%	135
2022 Q4	$1.55M	Buy	+13,972	New	+$1.43M	0.22%	86

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Marex Group's MRK Position: Q1 2026 in Review

Marex Group increased its Merck (MRK) stake by 118% in Q1 2026, buying an estimated $681K and bringing the position to 10,904 shares worth $1.31M. The position accounts for 0.01% of the portfolio, ranked #386.

Marex Group first reported a position in MRK in Q4 2022 and has held it in 13 quarters since. The position peaked at $13.7M in Q4 2023. 3,776 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Marex Group held 10,904 shares of Merck worth $1.31M as of Q1 2026.
Marex Group bought 5,896 Merck shares in Q1 2026, an estimated $681K.
Merck made up 0.01% of Marex Group's portfolio in Q1 2026, its #386 holding.
Marex Group first reported a position in Merck in Q4 2022 and has held it in 13 quarters since.
Marex Group's Merck position peaked at $13.7M in Q4 2023.
3,776 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.